GENESIS MINERALS LIMITED (GMD)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

GMD

GMD - GENESIS MINERALS LIMITED

FNArena Sector : Gold & Silver
Year End: June
GICS Industry Group : Materials
Debt/EBITDA: 0.44
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$7.10

03 Feb
2026

0.130

OPEN

$7.03

1.87%

HIGH

$7.29

5,924,080

LOW

$7.00

TARGET
$9.475

+0.77 change from previous day

33.5% upside
OTHER COMPANIES IN THE SAME SECTOR
A1M . AAM . AAR . ALK . AMI . ASL . AUC . AUE . AWJ . BC8 . BEZ . BGL . BNZ . BTR . CEL . CMM . CNB . CVV . CY5 . CYL . DPM . EMR . EVN . EVR . FFM . FFM . FXG . GG8 . GGP . GPR . HGO . HRZ . IGO . KAI . KCN . KGL . MAT . MAU . MEI . MEK . MM8 . MML . NEM . NMG . NST . NVA . OBM . ORE . PDI . PNR . PRU . RMS . RRL . RSG . RXL . RXR . SBM . SMI . SS1 . STM . STN . SVL . TBR . TCG . TOR . TRE . TTM . USL . VAU . WAF . WGX . WIA . WMX .
FNARENA'S MARKET CONSENSUS FORECASTS
GMD: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx 20.3 55.5 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx 100.0% 100.0% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 13.2 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx20.3
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx920.1 M
Book Value Per Share xxxxxxxxxxxxxxx110.9
Net Operating Cash Flow xxxxxxxxxxxxxxx420.7 M
Net Profit Margin xxxxxxxxxxxxxxx24.04 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx19.70 %
Return on Invested Capital xxxxxxxxxxxxxxx18.02 %
Return on Assets xxxxxxxxxxxxxxx14.38 %
Return on Equity xxxxxxxxxxxxxxx19.70 %
Return on Total Capital xxxxxxxxxxxxxxx25.22 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx252.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx23 M
Long Term Debt xxxxxxxxxxxxxxx178 M
Total Debt xxxxxxxxxxxxxxx201 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx240 M
Price To Book Value xxxxxxxxxxxxxxx3.88

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx183.1 M
Capex % of Sales xxxxxxxxxxxxxxx19.89 %
Cost of Goods Sold xxxxxxxxxxxxxxx571 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx35 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx25 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

02/02/2026

1

Buy

$10.00

40.85%

UBS global strategy team has upgraded near-term gold pricing, viewing US$5,200/oz as sustainable for the balance of 2026, before "tapering".

Across the Australian stock coverage, gold equities are pricing between US$3,235/oz and US$4,200/oz compared to the broker's new peak forecast (US$5,200/oz).

Genesis Minerals remains Buy rated with a higher target of $10 from $8.50 due to its growth profile.

UBS raises EPS forecasts by 20% for FY26 and 25% for FY27.

FORECAST
UBS forecasts a full year FY26 dividend of 0.00 cents and EPS of 55.00 cents.
UBS forecasts a full year FY27 dividend of 0.00 cents and EPS of 68.00 cents.

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Moelis

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Canaccord Genuity

13/01/2026

1

Buy

$9.60

35.21%

Canaccord Genuity lifted its long-term gold price forecast by 3.5% to US$4,909/oz from 2029 and raised medium-term estimates by 2.1% (2026-28). The broker's long-term forex forecasts are unchanged, leading to a 3.5% rise in gold price estimate in AUD terms to $7,013/oz.

The broker also increased the long-term silver price forecast by 36.6% to US$77.7/oz. 

Price targets for senior and intermediate/junior producers lifted by an average 5% after factoring in revised forecasts.

The broker expects Genesis Minerals to report -6% q/q decline in December quarter production. That forecast is 2% higher than consensus.

Buy. Target price $9.60.

GMD STOCK CHART